FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

AdvaMed Concerned with Device Remanufacturing Guide

Advanced Medical Technology Association says there are inconsistencies and ongoing concerns with FDAs guidance on remanufacturing/servicing medical de...

latest-news-card-1
Human Drugs

Regeneron Urges New Guidances for Precision Medicine

Regeneron calls on FDA to develop two guidances to further the use of precision medicine in non-oncology diseases.

latest-news-card-1
Human Drugs

Glenmark Pharma Recalls Potassium Chloride

Glenmark Pharmaceuticals recalls (Class 1) 114 batches of potassium chloride extended-release capsules, USP (750 mg), due to dissolution concerns.

Biologics

Biden Pressured FDA for Pfizer Covid Vaccine: House Report

A House subcommittee report claims that FDA cut corners in its usually rigorous processes and bowed to Biden Administration political pressure in appr...

latest-news-card-1
Human Drugs

Small Entity Compliance Guide on LDT Phase-out

FDA releases a guidance entitled Laboratory Developed Tests: Small Entity Compliance Guide.

Medical Devices

Endotronix Pulmonary Artery Sensor Approved

FDA approves an Endotronix PMA for its Cordella Pulmonary Artery Sensor System for treating New York Heart Failure Class III heart failure patients.

latest-news-card-1
Human Drugs

Committee Finds Troubling Foreign Inspection Issues

The House Energy and Commerce Committee seeks additional inspection records from FDA after its analysis of the foreign drug inspection program found t...

latest-news-card-1
Human Drugs

FDA Denies Petition Seeking Wakix Withdrawal

FDA denies a 4/2023 petition that called on the agency to withdraw approval for Harmony Biosciences Wakix (pitolisant) and take other actions against ...

latest-news-card-1
Human Drugs

Vyvgart Hytrulo OKd for Demyelinating Polyneuropathy

FDA approves Halozyme Therapeutics Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for treating chronic inflammatory demyelinating polyneur...

latest-news-card-1
Federal Register

Workshop in User Fee Meeting Management

Federal Register notice: FDA announces a 7/22 public workshop entitled Best Practices for Meeting Management.